- Tufts University School of Medicine, Boston, Massachusetts – MD
- Bellevue Hospital, New York University, New York, New York – Residency in Internal Medicine
- University of California San Diego Medical Center – Fellowship in Hematology/Oncology
Dr. Natalie Callander is a faculty member in Division of Hematology, Medical Oncology and Palliative Care within the Department of Medicine. She is the Director of the UW Carbone Cancer Center Myeloma Clinical Program, Vice Chair of the NCCN Myeloma Committee, and Interim Director of Bone Marrow Transplant. She is a member of the NCI Myeloma Steering Committee and the ECOG Myeloma Committee
She has received three UW Health Patient Experience Physician Champion Awards, named to Best Doctors in America list since 2004, a Madison Magazine Top Doctor three times, and received the Chuck Koval Award for Excellence in Myeloma presented by the Leukemia and Lymphoma Society.
Dr. Callander’s clinical focus is on multiple myeloma, malignant hematology, transplant and quality of life.
View Dr. Natalie Callander’s publications on NCBI MyBibliography.
Dr. Callander’s current research is focusing on new therapies in all stages of multiple myeloma and the development of clinical trials. She is the Principal Investigator on a national trial looking at early treatment for smoldering myeloma. She is also actively involved in the development of cellular therapies for multiple myeloma.